Spain, traditionally recognized as one of the big five European countries in the medtech industry, continues to demonstrate significant growth in various surgical procedure segments. According to the latest data from LSI’s Global Surgical Procedure Volumes Database, three segments are experiencing expansion at a particularly notable rate: Stereotactic Radiosurgery (SRS) procedures, Urological procedures, and Spine procedures.
Stereotactic Radiosurgery, non-invasive intervention that applies focused radiation beams to treat tumors and other abnormalities in the brain and body, is one of the fastest-growing segments in Spain’s medtech market. LSI’s medtech market Intelligence teams projects a compound annual growth rate (CAGR) for SRS procedures at 6.4% from 2023 to 2030. Within this segment, the following sub-segments are experiencing the most rapid growth:
These procedures target brain tumors and other intracranial abnormalities with precision, aiming to minimize damage to surrounding healthy tissues.
Targeting lung tumors and other thoracic conditions, these procedures are increasingly utilized due to their effectiveness and non-invasive nature.
These include treatments for abnormalities in regions outside the brain, demonstrating versatility in application.
The growth in SRS procedures underscores the advancements in precision medicine and the increasing preference for non-invasive treatment options among patients and healthcare providers in Spain.
Urological surgeries are another rapidly expanding segment, with a projected CAGR of 5.2% from 2023 to 2030. The growth in this segment is driven by the increasing prevalence of urological conditions and advancements in surgical techniques driven by medical technology companies. Key sub-segments include:
This procedure, often used to treat benign prostatic hyperplasia (BPH), involves removing prostate tissue through the urethra, offering a minimally invasive solution for patients.
This non-invasive procedure uses shock waves to break up kidney stones, making it a preferred option for patients due to its reduced recovery time and minimal complications.
Various other surgical techniques to treat BPH are also gaining traction, contributing to the overall growth in urological procedures.
The rising incidence of urological conditions, coupled with medical technology advancements, is fueling the growth in this segment, making it a key area of focus for medtech companies in Spain.
Spine surgeries in Spain are projected to grow at a CAGR of 4.8% from 2023 to 2030. This growth is driven by the increasing demand for procedures that address spinal conditions, as well as advancements in implants and other interventional approaches. Key sub-segments include:
These spacers are used to treat lumbar spinal stenosis, offering a minimally invasive option that can significantly improve patient outcomes.
This procedure involves the injection of bone cement into a fractured vertebra, providing pain relief and stabilization for patients with vertebral compression fractures.
As an alternative to spinal fusion, disc replacements preserve more of the natural movement of the spine, leading to better long-term outcomes for patients.
The growth in spine procedures highlights the ongoing advancements in spinal surgery and the increasing demand for effective treatments for spinal disorders.
For more coverage of global procedure volumes, LSI offers a comprehensive suite of medtech market intelligence solutions provided by our in-house team of career-Medtech insiders. Our Global Procedure Volumes Database is the industry's most comprehensive and trusted product of its kind, with coverage of 200+ diagnostic and therapeutic procedures in 12 major categories across 37 countries. Visit our website to see how our products and services can help you say goodbye to overpriced, bloated market reports forever.
Schedule an exploratory call
Request Info© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
.png)
